• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟丙基-β-环糊精对冷冻干燥和γ辐照的 PLGA 和 PLGA-PEG 两亲嵌段共聚物纳米球在眼部氟比洛芬给药中的作用。

Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.

机构信息

Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Av Joan XXIII s/n, Barcelona, Spain.

出版信息

Int J Nanomedicine. 2012;7:1357-71. doi: 10.2147/IJN.S28481. Epub 2012 Mar 9.

DOI:10.2147/IJN.S28481
PMID:22457594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3310410/
Abstract

Poly(D,L-lactide-co-glycolide) and poly(D,L-lactide-co-glycolide) with poly(ethylene glycol) nanospheres (NSs) incorporating flurbiprofen (FB) were freeze-dried with several cryoprotective agents and sterilized by γ-irradiation. Only when 5.0% (w/v) hydroxypropyl-β-cyclodextrin (HPβCD) was used, a complete resuspension by manual shaking and almost identical particle size of the NSs was obtained after freeze-drying. In vitro drug release and ex vivo corneal permeation of NSs with and without HPβCD were evaluated. The presence of HPβCD resulted in a reduction of burst effect, providing a more sustained release of the drug. A significant decrease in the FB transcorneal permeation of NSs containing HPβCD was obtained, related to the slower diffusion of FB observed in the in vitro results. The uptake mechanism of the NSs was examined by confocal microscopy, suggesting that NSs penetrate corneal epithelium through a transcellular pathway. Ocular tolerance was assessed in vitro and in vivo by the Eytex™ and Draize test, respectively. Long-term stability studies revealed that γ-irradiated NSs stored as freeze-dried powders maintained their initial characteristics. Stability studies of the resuspended NSs after 3 months of storage in the aqueous form showed that NSs were stable at 4°C, while formulations stored at 25°C and 40°C increased their initial particle size.

摘要

聚(D,L-丙交酯-共-乙交酯)和聚(D,L-丙交酯-共-乙交酯)纳米球(NSs)与氟比洛芬(FB)结合的纳米球(NSs)用几种冷冻保护剂冷冻干燥,并通过γ-射线灭菌。只有当使用 5.0%(w/v)羟丙基-β-环糊精(HPβCD)时,通过手动摇晃才能完全重新悬浮,并且在冷冻干燥后 NSs 的粒径几乎相同。评估了含有和不含有 HPβCD 的 NSs 的体外药物释放和体外角膜渗透。存在 HPβCD 导致了突释效应的减少,提供了药物更持续的释放。含有 HPβCD 的 NSs 中 FB 的跨角膜渗透显著减少,这与在体外观察到的 FB 扩散速度较慢有关。通过共聚焦显微镜检查了 NSs 的摄取机制,表明 NSs 通过细胞间途径穿透角膜上皮。通过 Eytex™和 Draize 测试分别在体外和体内评估了眼耐受性。长期稳定性研究表明,γ-辐照的 NSs 以冷冻干燥粉末的形式储存,保持其初始特性。在水相中储存 3 个月后重新悬浮的 NSs 的稳定性研究表明,NSs 在 4°C 下稳定,而在 25°C 和 40°C 下储存的制剂会增加其初始粒径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/533a5a4d7fb9/ijn-7-1357f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/4faca5bca8b1/ijn-7-1357f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/e467d9cabcf8/ijn-7-1357f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/bd9267f2369e/ijn-7-1357f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/eb86ea72c594/ijn-7-1357f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/d3cdc283e8f7/ijn-7-1357f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/533a5a4d7fb9/ijn-7-1357f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/4faca5bca8b1/ijn-7-1357f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/e467d9cabcf8/ijn-7-1357f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/bd9267f2369e/ijn-7-1357f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/eb86ea72c594/ijn-7-1357f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/d3cdc283e8f7/ijn-7-1357f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd5b/3310410/533a5a4d7fb9/ijn-7-1357f6.jpg

相似文献

1
Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.羟丙基-β-环糊精对冷冻干燥和γ辐照的 PLGA 和 PLGA-PEG 两亲嵌段共聚物纳米球在眼部氟比洛芬给药中的作用。
Int J Nanomedicine. 2012;7:1357-71. doi: 10.2147/IJN.S28481. Epub 2012 Mar 9.
2
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.氟比洛芬 PLGA-PEG 纳米球:羟丙基-β-环糊精对离体人皮肤渗透和体内局部抗炎功效的作用。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:339-46. doi: 10.1016/j.colsurfb.2013.04.045. Epub 2013 May 4.
3
Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.使用d-(+)-海藻糖和聚乙二醇的氟比洛芬聚合物纳米粒用于眼部给药的临床前研究中冻干和γ射线辐照的影响
Int J Nanomedicine. 2016 Aug 23;11:4093-106. doi: 10.2147/IJN.S105606. eCollection 2016.
4
The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.不同冷冻保护剂的冷冻干燥及γ射线辐照灭菌对载盐酸环丙沙星聚(D,L-丙交酯-乙交酯)纳米粒特性的影响
J Pharm Pharmacol. 2005 Jun;57(6):699-707. doi: 10.1211/0022357056145.
5
Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.载吡格列酮的 PLGA-PEG 纳米球的优化、生物制药特性和治疗效果:一种治疗眼部炎症性疾病的新策略。
Pharm Res. 2018 Jan 3;35(1):11. doi: 10.1007/s11095-017-2319-8.
6
PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.用于氟比洛芬眼部给药的聚乳酸-羟基乙酸共聚物纳米球:药物释放与相互作用
J Pharm Sci. 2008 Dec;97(12):5306-17. doi: 10.1002/jps.21383.
7
PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).载前列腺素 E1-羟丙基-β-环糊精(PGE1-HPβCD)复合物的 PLGA 微球用于治疗肺动脉高压(PAH)。
Pharm Res. 2011 Jul;28(7):1733-49. doi: 10.1007/s11095-011-0409-6. Epub 2011 Apr 6.
8
Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.地洛瑞林的肺部给药:大孔聚乳酸-羟基乙酸共聚物微粒和羟丙基-β-环糊精复合物
Pharm Res. 2004 Jul;21(7):1119-26. doi: 10.1023/b:pham.0000032997.96823.88.
9
Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.制剂参数对注射用圆柱形聚(DL-丙交酯-乙交酯)植入物中2-甲氧基雌二醇释放的影响。
Eur J Pharm Biopharm. 2008 Sep;70(1):187-98. doi: 10.1016/j.ejpb.2008.03.007. Epub 2008 Mar 20.
10
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.通过实验设计优化的聚乙二醇化聚乳酸-羟基乙酸共聚物纳米球用于右布洛芬的眼部给药——体外、离体和体内表征
Colloids Surf B Biointerfaces. 2016 Sep 1;145:241-250. doi: 10.1016/j.colsurfb.2016.04.054. Epub 2016 May 3.

引用本文的文献

1
Novel Tissue-Specific Multifunctionalized Nanotechnological Platform Encapsulating Riluzole Against Motor Neuron Diseases.新型组织特异性多功能纳米技术平台包裹利鲁唑治疗运动神经元疾病
Int J Nanomedicine. 2025 Feb 21;20:2273-2288. doi: 10.2147/IJN.S479819. eCollection 2025.
2
Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery.聚(乳酸-乙醇酸)纳米颗粒的制备、功能化及药物递送的生物学考量
Biomicrofluidics. 2024 Sep 17;18(5):051503. doi: 10.1063/5.0201465. eCollection 2024 Sep.
3
Sustainability in Drug and Nanoparticle Processing.

本文引用的文献

1
An in vitro method for estimating ocular irritation.一种评估眼刺激性的体外方法。
Toxicol In Vitro. 1990;4(4-5):332-5. doi: 10.1016/0887-2333(90)90076-6.
2
Acceptance of in vitro studies by regulatory authorities.监管机构对体外研究的认可。
Toxicol In Vitro. 1994 Aug;8(4):911-6. doi: 10.1016/0887-2333(94)90098-1.
3
Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea.噻吗洛尔从表面改性固体脂质纳米粒通过生物工程化人角膜的缓释与渗透。
药物与纳米颗粒加工中的可持续性。
Handb Exp Pharmacol. 2024;284:45-68. doi: 10.1007/164_2023_659.
4
Development of Lyophilised Eudragit Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration.用于通过鼻内给药实现氯氮平缓释的冻干型Eudragit缓释纳米颗粒的研制。
Pharmaceutics. 2023 May 21;15(5):1554. doi: 10.3390/pharmaceutics15051554.
5
Precision Medicines for Retinal Lipid Metabolism-Related Pathologies.用于视网膜脂质代谢相关病症的精准药物。
J Pers Med. 2023 Apr 5;13(4):635. doi: 10.3390/jpm13040635.
6
Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: , and studies.两性霉素B和乳铁蛋白组合负载的PLGA-PEG-PEI纳米粒热敏水凝胶用于潜在根除眼部真菌感染的研究: 、 及 研究
Int J Pharm X. 2023 Feb 28;5:100174. doi: 10.1016/j.ijpx.2023.100174. eCollection 2023 Dec.
7
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.载有左旋多巴和姜黄素的可生物降解纳米粒子治疗帕金森病。
Molecules. 2022 Apr 28;27(9):2811. doi: 10.3390/molecules27092811.
8
Cyclodextrin Stabilized Freeze-Dried Silica/Chitosan Nanoparticles for Improved Terconazole Ocular Bioavailability.环糊精稳定的冻干二氧化硅/壳聚糖纳米颗粒用于提高特康唑的眼部生物利用度
Pharmaceutics. 2022 Feb 22;14(3):470. doi: 10.3390/pharmaceutics14030470.
9
Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation.用于眼部炎症的载有甘草查尔酮A的肽靶向聚乳酸-羟基乙酸共聚物-聚乙二醇化纳米颗粒的研发
Pharmaceutics. 2022 Jan 26;14(2):285. doi: 10.3390/pharmaceutics14020285.
10
Quantifying the effect of PEG architecture on nanoparticle ligand availability using DNA-PAINT.使用DNA-PAINT量化聚乙二醇(PEG)结构对纳米颗粒配体可用性的影响。
Nanoscale Adv. 2021 Nov 1;3(24):6876-6881. doi: 10.1039/d1na00696g. eCollection 2021 Dec 7.
Curr Eye Res. 2009 Aug;34(8):698-705. doi: 10.1080/02713680903017500.
4
Nanomedicines for ocular NSAIDs: safety on drug delivery.眼用 NSAIDs 的纳米药物:药物递送的安全性。
Nanomedicine. 2009 Dec;5(4):394-401. doi: 10.1016/j.nano.2009.02.003. Epub 2009 Mar 31.
5
An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles.一种离子对方法,用于增加亲水性和脂溶性药物在聚乙二醇化聚乳酸-羟基乙酸共聚物纳米颗粒中的载药量。
Eur J Pharm Biopharm. 2009 Feb;71(2):231-42. doi: 10.1016/j.ejpb.2008.08.004. Epub 2008 Aug 17.
6
PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.用于氟比洛芬眼部给药的聚乳酸-羟基乙酸共聚物纳米球:药物释放与相互作用
J Pharm Sci. 2008 Dec;97(12):5306-17. doi: 10.1002/jps.21383.
7
Freeze-drying of nanoparticles: formulation, process and storage considerations.纳米颗粒的冷冻干燥:制剂、工艺及储存考量
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1688-713. doi: 10.1016/j.addr.2006.09.017. Epub 2006 Oct 6.
8
Lyoprotected nanosphere formulations for paclitaxel controlled delivery.用于紫杉醇控释的冻干保护纳米球制剂
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3118-25. doi: 10.1166/jnn.2006.452.
9
Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.用于眼部给药的载氟比洛芬可生物降解纳米颗粒
J Pharm Sci. 2006 Nov;95(11):2393-405. doi: 10.1002/jps.20685.
10
Plasticization of poly(L-lactide) with poly(propylene glycol).聚(L-丙交酯)与聚丙二醇的增塑作用。
Biomacromolecules. 2006 Jul;7(7):2128-35. doi: 10.1021/bm060089m.